A Study of Mobocertinib in Japanese Adults With Non-Small Cell Lung Cancer
Clinical trial NCT03807778 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03807778
- Sponsor
- Takeda
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-04
- Primary completion
- 2021-11-08
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.